The rating affirmation is based on Summit’s strong operating results and leading market position.
Summit Health also faces challenges, including service area competition, pressured volumes and the upcoming implementation of a new EHR.
The outlook is stable, reflecting Moody’s Investors Service’s expectation that Summit will continue to generate solid operating results.
More articles on healthcare finance:
Moody’s assigns ‘A1’ rating to Arkansas Children’s Hospital’s bonds
The top 8 takeaways from HFMA’s 2016 National Institute
CMS considers modifications to ambitious Medicare Part B payment experiment
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
